The research showed that in the last decade, the value of healthcare public procurement contracts has increased by more than double, while the number of economic operators awarded such contracts was increased by only 12%, which indicates a concentration of funds among a limited number of suppliers. With the growth in the value of tenders, the share of the ten largest holders of public procurement contracts has decreased from 62% in 2015 to 49% in 2024, which indicates a moderate decrease in concentration. Two companies, Alkaloid Kons and D-r Panovski strengthened their dominant position on the healthcare public procurement market and nowadays control one quarter of the total value of tender procedures in this sector. When analysed at the level of public procurements organized for medicines, medical supplies and medical equipment their combined share increases to one third.
This research is conducted as part of the project “Combating Corruption in Healthcare Public Procurement”, implemented by the Centre for Civil Communications with financial support from the National Endowment for Democracy (NED).